These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19682036)

  • 1. Vigabatrin therapy in infantile spasms: solving one problem and inducing another?
    Wohlrab G; Leiba H; Kästle R; Ramelli G; Schmitt-Mechelke T; Schmitt B; Landau K
    Epilepsia; 2009 Aug; 50(8):2006-8. PubMed ID: 19682036
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the risk of vigabatrin-attributed visual field loss lower in infancy than in later life?
    Riikonen R
    Epilepsia; 2009 Aug; 50(8):2005-6. PubMed ID: 19682035
    [No Abstract]   [Full Text] [Related]  

  • 3. Vigabatrin administration in patients with infantile spasms: the risks.
    Jaseja H
    Clin Neurol Neurosurg; 2010 Nov; 112(9):835. PubMed ID: 20934097
    [No Abstract]   [Full Text] [Related]  

  • 4. Visual fields at school-age in children treated with vigabatrin in infancy.
    Gaily E; Jonsson H; Lappi M
    Epilepsia; 2009 Feb; 50(2):206-16. PubMed ID: 19215279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of infantile spasms: new opportunities and emerging challenges.
    Mikati MA; Cornett KM
    Epilepsy Behav; 2010 Apr; 17(4):571-3. PubMed ID: 20097137
    [No Abstract]   [Full Text] [Related]  

  • 6. Seizure outcome in infantile spasms--a retrospective study.
    Mohamed BP; Scott RC; Desai N; Gutta P; Patil S
    Epilepsia; 2011 Apr; 52(4):746-52. PubMed ID: 21320111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infantile spasms and vigabatrin. Visual field defects may be permanent.
    Lhatoo SD; Sander JW
    BMJ; 1999 Jan; 318(7175):57. PubMed ID: 10068225
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual field constriction is not limited to children treated with vigabatrin.
    Wohlrab G; Boltshauser E; Schmitt B; Schriever S; Landau K
    Neuropediatrics; 1999 Jun; 30(3):130-2. PubMed ID: 10480207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE; Major P; Halpern E; Thiele EA
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral MRI abnormalities associated with vigabatrin therapy.
    Pearl PL; Vezina LG; Saneto RP; McCarter R; Molloy-Wells E; Heffron A; Trzcinski S; McClintock WM; Conry JA; Elling NJ; Goodkin HP; de Menezes MS; Ferri R; Gilles E; Kadom N; Gaillard WD
    Epilepsia; 2009 Feb; 50(2):184-94. PubMed ID: 18783433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigabatrin for infantile spasms.
    Pesaturo KA; Spooner LM; Belliveau P
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin monotherapy for infantile spasms.
    Gaily E
    Expert Rev Neurother; 2012 Mar; 12(3):275-86. PubMed ID: 22364326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual field constriction on vigabatrin.
    Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin: an antiepileptic drug with major benefits but significant adverse effects.
    Besag FM
    Curr Drug Saf; 2010 Jul; 5(3):188-90. PubMed ID: 20624131
    [No Abstract]   [Full Text] [Related]  

  • 15. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Justification of vigabatrin administration in West syndrome patients? Warranting a re-consideration for improvement in their quality of life.
    Jaseja H
    Clin Neurol Neurosurg; 2009 Feb; 111(2):111-4. PubMed ID: 18845383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current role of vigabatrin in infantile spasms.
    Parisi P; Bombardieri R; Curatolo P
    Eur J Paediatr Neurol; 2007 Nov; 11(6):331-6. PubMed ID: 17625936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of vigabatrin treatment causing visual field defects in infantile spasms.
    Chiron C; Dulac O
    Dev Med Child Neurol; 2015 Jan; 57(1):9-10. PubMed ID: 25109842
    [No Abstract]   [Full Text] [Related]  

  • 19. Measuring field loss in children administered vigabatrin: a problem in search of a solution.
    Good WV
    J AAPOS; 2011 Oct; 15(5):411-2. PubMed ID: 22108349
    [No Abstract]   [Full Text] [Related]  

  • 20. Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study.
    Riikonen R; Rener-Primec Z; Carmant L; Dorofeeva M; Hollody K; Szabo I; Krajnc BS; Wohlrab G; Sorri I
    Dev Med Child Neurol; 2015 Jan; 57(1):60-7. PubMed ID: 25145415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.